| Tag | Content |
|---|
EnhancerAtlas ID | HS109-04627 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr11:72526550-72527770 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SPI1 | MA0080.4 | chr11:72526879-72526893 | GAAAAGAGGAAGTG | + | 6.92 | | Zfx | MA0146.2 | chr11:72527268-72527282 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
| SE_09492 | chr11:72516744-72529629 | CD14 | | SE_10921 | chr11:72523402-72528230 | CD20 | | SE_13957 | chr11:72523137-72527992 | CD34_Primary_RO01536 | | SE_19499 | chr11:72523500-72528138 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20435 | chr11:72523391-72528049 | CD56 | | SE_22753 | chr11:72523280-72528009 | CD8_primiary | | SE_42971 | chr11:72523490-72527154 | Lung | | SE_42971 | chr11:72527208-72527987 | Lung | | SE_53568 | chr11:72522423-72528361 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CCCCTGCCCC CCGCCCCGAC CCAGGGAGCT GTGAGTCTGA GGGACTAGAG AGATCTGGAG 60
GGCTGAAATC AGACTGAAGG GCCAGTCTTG AAACCTTGGG CAGATCACAT CGCTAAGCCT 120
CAGTCTTCTT ACTTGTTAAT TGGGTATAGA GACCTTCTTT AGGTTTGCTG GGTGCTGCAG 180
TACCCTGGGG GCTGAGGTGG GGTTTTCATG AGAACTAGGC CAGGCCCAGG GCCTCAGTCA 240
AGGTGACAGG GCACTGAGTG TGGGAAGGAA GTTGATGAGG AGGGAGCTAG GCCCGGACTT 300
ACCACCCCAC CCTCCCCTGG AACTGGTGAG AAAAGAGGAA GTGACTGTTG ATGGGGGAGG 360
GTGTTCCAGG GTCAAACCAC CAACCTCCAG AATGTCGGCT GGATAATTGC TCAAGGACTT 420
TCTATTCTGG CCTGGGGGTA CCTTACACCA GGGCTGGGGA AGTTGGGATT ATTTATTTAT 480
TTATTTATTT GAGATGGAGT CTTTGCTCTG TTGCCCAGGC TGGAGTGCAG TGGTGTGATC 540
TCCGCTCACT GCAAGCTCTG CCTCCCAAGT TCACGCCTGT CTCCCGTCTC AGCCTCCCGA 600
GTAGCTGGGA CTACAGGCGC CTGCCACCAC GCCTGGCTAA TTTTTTGTAT TTTTTAGTAG 660
AGATGGGGGT TTCACCGTGT TAGCCAGGAT GGTCTCGATC TCCTGACCTC GTGATCCGCC 720
CGCCTCGGCC TCCCAGAGCG CTGGGAATTC AGGTGTGAGC CACCGCGCCC GGCTGGGGAT 780
TATTTTTAAG TGCAGAAAGC TAGAGCCCTT GGAGGGGAAG TGACTTGCCA AAGGCCATTG 840
ACAGGTAGAG CTCGGTTTAT TTCATCACTT TCTGGGGCTA AGCCTTGCTC TGAGGCAGGG 900
ATGAATCAAT CCCAGGCCCC TTCCTTCCCT CAGGACCCTC AGCGGGCAGT ACCCCGCAGT 960
GGTCATCCTT CTGTCCCTGG GAGAGCAGGT CCTCTTCCAC GTGGGCCTGG GGACCGGTGC 1020
TATGAGGACA CTGCTAGGGC TGAAGGTCCT GTAGAACTGC ACAGATGCCC CTCAGGCACA 1080
GGGCAGAGGC CAGCCTGCCA GAAGCTTCCC CATCCCTAGC ATCTCTGGGC TCCTTCAGCC 1140
CTTTTAGCCG GAGATAAATT GCATGCCAGG GGGCTGCTGG GTATCTGTCT CTGCCCCAGG 1200
CTCACTCTCT TGCACTCTCC 1220
|
